Clinical Trial: Multi-center Prospective Validation of Real-Time AI-EGGIM System

U.S., Nov. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07915843) titled 'Multi-center Prospective Validation of Real-Time AI-EGGIM System' on Oct. 29.

Brief Summary: Gastric intestinal metaplasia (GIM) is a precancerous condition associated with an increased risk of gastric cancer. The endoscopic grading of gastric intestinal metaplasia (EGGIM) score evaluates the extent of GIM across five standard gastric regions. The investigators developed a real-time artificial intelligence-assisted EGGIM (AI-EGGIM) system that automatically assigns an intestinal metaplasia grade to each region and calculates a total EGGIM score.

This prospective multi-center validation study will consecutively enroll patients underg...